Cargando…

An α-chloroaldehyde-based formal synthesis of eribulin

Eribulin (Halaven) is the most structurally complex non-peptidic drug made by total synthesis and has challenged preconceptions of synthetic feasibility in drug discovery and development. However, despite decades of research, the synthesis and manufacture of eribulin remains a daunting task. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaghad, Anissa, Panagopoulos, Dimitrios, Caballero-García, Guillermo, Zhai, Huimin, Britton, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076431/
https://www.ncbi.nlm.nih.gov/pubmed/37019928
http://dx.doi.org/10.1038/s41467-023-37346-7
_version_ 1785020129969438720
author Kaghad, Anissa
Panagopoulos, Dimitrios
Caballero-García, Guillermo
Zhai, Huimin
Britton, Robert
author_facet Kaghad, Anissa
Panagopoulos, Dimitrios
Caballero-García, Guillermo
Zhai, Huimin
Britton, Robert
author_sort Kaghad, Anissa
collection PubMed
description Eribulin (Halaven) is the most structurally complex non-peptidic drug made by total synthesis and has challenged preconceptions of synthetic feasibility in drug discovery and development. However, despite decades of research, the synthesis and manufacture of eribulin remains a daunting task. Here, we report syntheses of the most complex fragment of eribulin (C14–C35) used in two distinct industrial routes to this important anticancer drug. Our convergent strategy relies on a doubly diastereoselective Corey–Chaykovsky reaction to affect the union of two tetrahydrofuran-containing subunits. Notably, this process relies exclusively on enantiomerically enriched α-chloroaldehydes as building blocks for constructing the three densely functionalized oxygen heterocycles found in the C14–C35 fragment and all associated stereocenters. Overall, eribulin can now be produced in a total of 52 steps, which is a significant reduction from that reported in both academic and industrial syntheses.
format Online
Article
Text
id pubmed-10076431
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100764312023-04-07 An α-chloroaldehyde-based formal synthesis of eribulin Kaghad, Anissa Panagopoulos, Dimitrios Caballero-García, Guillermo Zhai, Huimin Britton, Robert Nat Commun Article Eribulin (Halaven) is the most structurally complex non-peptidic drug made by total synthesis and has challenged preconceptions of synthetic feasibility in drug discovery and development. However, despite decades of research, the synthesis and manufacture of eribulin remains a daunting task. Here, we report syntheses of the most complex fragment of eribulin (C14–C35) used in two distinct industrial routes to this important anticancer drug. Our convergent strategy relies on a doubly diastereoselective Corey–Chaykovsky reaction to affect the union of two tetrahydrofuran-containing subunits. Notably, this process relies exclusively on enantiomerically enriched α-chloroaldehydes as building blocks for constructing the three densely functionalized oxygen heterocycles found in the C14–C35 fragment and all associated stereocenters. Overall, eribulin can now be produced in a total of 52 steps, which is a significant reduction from that reported in both academic and industrial syntheses. Nature Publishing Group UK 2023-04-05 /pmc/articles/PMC10076431/ /pubmed/37019928 http://dx.doi.org/10.1038/s41467-023-37346-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kaghad, Anissa
Panagopoulos, Dimitrios
Caballero-García, Guillermo
Zhai, Huimin
Britton, Robert
An α-chloroaldehyde-based formal synthesis of eribulin
title An α-chloroaldehyde-based formal synthesis of eribulin
title_full An α-chloroaldehyde-based formal synthesis of eribulin
title_fullStr An α-chloroaldehyde-based formal synthesis of eribulin
title_full_unstemmed An α-chloroaldehyde-based formal synthesis of eribulin
title_short An α-chloroaldehyde-based formal synthesis of eribulin
title_sort α-chloroaldehyde-based formal synthesis of eribulin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076431/
https://www.ncbi.nlm.nih.gov/pubmed/37019928
http://dx.doi.org/10.1038/s41467-023-37346-7
work_keys_str_mv AT kaghadanissa anachloroaldehydebasedformalsynthesisoferibulin
AT panagopoulosdimitrios anachloroaldehydebasedformalsynthesisoferibulin
AT caballerogarciaguillermo anachloroaldehydebasedformalsynthesisoferibulin
AT zhaihuimin anachloroaldehydebasedformalsynthesisoferibulin
AT brittonrobert anachloroaldehydebasedformalsynthesisoferibulin
AT kaghadanissa achloroaldehydebasedformalsynthesisoferibulin
AT panagopoulosdimitrios achloroaldehydebasedformalsynthesisoferibulin
AT caballerogarciaguillermo achloroaldehydebasedformalsynthesisoferibulin
AT zhaihuimin achloroaldehydebasedformalsynthesisoferibulin
AT brittonrobert achloroaldehydebasedformalsynthesisoferibulin